Market revenue in 2023 | USD 1,227.5 million |
Market revenue in 2030 | USD 1,761.9 million |
Growth rate | 5.3% (CAGR from 2023 to 2030) |
Largest segment | Liquid delivery device |
Fastest growing segment | Liquid Delivery Device |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Powder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler |
Key market players worldwide | GSK PLC ADR, Teva Pharmaceutical Industries Ltd, AptarGroup Inc, UCB SA, Teleflex Inc, 3M Co, OptiNose Inc, Bespak, Intersect ENT |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intranasal drug and vaccine delivery market will help companies and investors design strategic landscapes.
Liquid delivery device was the largest segment with a revenue share of 45.13% in 2023. Horizon Databook has segmented the Brazil intranasal drug and vaccine delivery market based on powder delivery device, liquid delivery device, pressurized metered dose inhaler covering the revenue growth of each sub-segment from 2018 to 2030.
The intranasal drug and vaccine delivery market in Brazil is estimated to witness growth during the forecast period owing to increase in the number of healthcare reforms and rise in healthcare expenditure. In addition, the U.S. hospitals have been affiliated with Brazilian hospitals for telemedicine, education, and second opinion programs.
Moreover, growing partnerships and mergers between industries & government and increasing demand for cost-effective & technologically upgraded equipment are some of the key factors propelling market growth. Brazil is also known to be one of the largest markets for medical devices in Latin America.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil intranasal drug and vaccine delivery market , including forecasts for subscribers. This country databook contains high-level insights into Brazil intranasal drug and vaccine delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account